I agree that this site is using cookies. You can find further informations here.
X
Gilabert-Oriol, Roger
63  results:
Articles (Online) X
Search for persons X
?
1

An unusual type I ribosome-inactivating protein from Agrost..:

Weise, Christoph ; Schrot, Achim ; Wuerger, Leonie T. D....
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
2

Recent Treatment Advances and the Role of Nanotechnology, C..:

Chen, Kent T. J. ; Gilabert-Oriol, Roger ; Bally, Marcel B..
Pharmaceutical Research.  36 (2019)  9 - p. , 2019
Link: https://doi.org/10.1007/..
 
?
3

Liposomal OTS964, a TOPK inhibitor: a simple method to esti..:

Gilabert-Oriol, Roger ; Sutherland, Brent W. ; Anantha, Malathi..
Drug Delivery and Translational Research.  9 (2019)  6 - p. 1082-1094 , 2019
Link: https://doi.org/10.1007/..
 
?
4

Liposomal Formulations to Modulate the Tumour Microenvironm..:

Gilabert-Oriol, Roger ; Ryan, Gemma M. ; Leung, Ada W.Y....
International Journal of Molecular Sciences.  19 (2018)  10 - p. 2922 , 2018
Link: https://doi.org/10.3390/..
 
?
5

Unique therapeutic properties and preparation methodology o..:

Popov, Jesse ; Gilabert-Oriol, Roger ; Bally, Marcel B.
European Journal of Pharmaceutics and Biopharmaceutics.  117 (2017)  - p. 256-269 , 2017
Link: https://doi.org/10.1016/..
 
?
6

In vitro assay for measuring real time topotecan release fr..:

Gilabert-Oriol, Roger ; Chernov, Lina ; Anantha, Malathi..
Drug Delivery and Translational Research.  7 (2017)  4 - p. 544-557 , 2017
Link: https://doi.org/10.1007/..
 
?
7

Dianthin-30 or gelonin versus monomethyl auristatin E, each..:

Gilabert-Oriol, Roger ; Furness, Sebastian G. B. ; Stringer, Brett W....
Cancer Immunology, Immunotherapy.  66 (2017)  9 - p. 1217-1228 , 2017
Link: https://doi.org/10.1007/..
 
?
8

A simple passive equilibration method for loading carboplat..:

Wehbe, Moe ; Malhotra, Armaan ; Anantha, Malathi...
Journal of Controlled Release.  252 (2017)  - p. 50-61 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Augmenting the Efficacy of Immunotoxins and Other Targeted ..:

Fuchs, Hendrik ; Weng, Alexander ; Gilabert-Oriol, Roger
Toxins.  8 (2016)  7 - p. 200 , 2016
Link: https://doi.org/10.3390/..
 
?
10

Improved intracellular delivery of peptide- and lipid-nanop..:

Weng, Alexander ; Manunta, Maria D.I. ; Thakur, Mayank...
Journal of Controlled Release.  206 (2015)  - p. 75-90 , 2015
Link: https://doi.org/10.1016/..
 
?
11

Electrophoretic mobility as a tool to separate immune adjuv..:

Gilabert-Oriol, Roger ; Weng, Alexander ; von Mallinckrodt, Benedicta...
International Journal of Pharmaceutics.  487 (2015)  1-2 - p. 39-48 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Combinatorial approach to increase efficacy of Cetuximab, P..:

Gilabert-Oriol, Roger ; Weng, Alexander ; Trautner, Alexandra...
Biochemical Pharmacology.  97 (2015)  3 - p. 247-255 , 2015
Link: https://doi.org/10.1016/..
 
?
13

Reporter Assay for Endo/Lysosomal Escape ofToxin-Based Ther..:

Gilabert-Oriol, Roger ; Thakur, Mayank ; Von Mallinckrodt, Benedicta...
Toxins.  6 (2014)  5 - p. 1644-1666 , 2014
Link: https://doi.org/10.3390/..
 
?
14

High-speed countercurrent chromatographic recovery and off-..:

Thakur, Mayank ; Jerz, Gerold ; Tuwalska, Dorota...
Journal of Chromatography B.  955-956 (2014)  - p. 1-9 , 2014
Link: https://doi.org/10.1016/..
 
?
15

Real-time analysis of membrane permeabilizing effects of ol..:

Gilabert-Oriol, Roger ; Mergel, Katharina ; Thakur, Mayank...
Bioorganic & Medicinal Chemistry.  21 (2013)  8 - p. 2387-2395 , 2013
Link: https://doi.org/10.1016/..
 
1-15